InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the full record of transactions filed by Michael Häggman, 董事. Director active across 1 company, notably Prostatype Genomics AB. In total, 3 reports have been recorded. Activity tracked since 5 June 2025. The latest transaction was filed on 5 August 2026 (Purchase). Regulator: FIN-FSA. All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 条申报中的 3 条
Michael Häggman is a Board Member of Prostatype Genomics AB. In this role, he participates in strategic decisions and oversees the company's operations. Michael brings his expertise and experience to support management in achieving Prostatype's objectives. His commitment to good governance is essential for the company's success.